These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15550959

  • 1. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN, Wisløff T, Fosså S, Sandberg S, Malde K, Forland F, Førde OH.
    Tidsskr Nor Laegeforen; 2004 Nov 18; 124(22):2893-5. PubMed ID: 15550959
    [Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS, Goel V, Williams JI, Iscoe NA.
    CMAJ; 1999 Jan 12; 160(1):70-5. PubMed ID: 9934349
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J.
    Patient Educ Couns; 2006 Nov 12; 63(3):367-79. PubMed ID: 16875796
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.
    Arch Intern Med; 2009 Sep 28; 169(17):1611-8. PubMed ID: 19786681
    [Abstract] [Full Text] [Related]

  • 8. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J, Low M, McLeod D.
    N Z Med J; 2003 Jun 20; 116(1176):U476. PubMed ID: 12835804
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Health technology assessment and implications for clinical practice: the case of prostate cancer screening.
    Norderhaug IN, Sandberg S, Fosså SD, Forland F, Malde K, Kvinnsland S, Traaholt I, Rossiné BK, Førde OH.
    Scand J Clin Lab Invest; 2003 Jun 20; 63(5):331-8. PubMed ID: 14599155
    [Abstract] [Full Text] [Related]

  • 13. [Practice patterns of general practitioners in the Loire-Atlantique region and their patients' knowledge of prostate cancer screening].
    Burin B, Bouchot O, Rigaud J.
    Prog Urol; 2006 Nov 20; 16(5):559-63. PubMed ID: 17175951
    [Abstract] [Full Text] [Related]

  • 14. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS, Sherin K, ACPM Prevention Practice Committee.
    Am J Prev Med; 2008 Feb 20; 34(2):164-70. PubMed ID: 18201648
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Timely screening routines for prostatic cancer by Norwegian physicians].
    Fosså SD, Eri LM.
    Tidsskr Nor Laegeforen; 1999 Oct 10; 119(24):3572-6. PubMed ID: 10563174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V, Jichlinski P, Aymon D, Leisinger HJ.
    Rev Med Suisse; 2005 Dec 07; 1(44):2840-2. PubMed ID: 16382715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.